• Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study Evaluating Direct Oral Anticoagulants for Prevention of Blood Clots in Patients with Hypertrophic Cardiomyopathy and Abnormal Left Atrial Function

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of THEO-260 for Patients with High-Grade Serous or Endometrioid Ovarian Cancer

    Recruiting

    2 1 1
    Investigated diseases:
    Spain

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France The Netherlands Norway Spain

  • Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Poland Spain

  • Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Germany Hungary Poland Spain

  • Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study of Etranacogene Dezaparvovec (CSL222) in Adolescent Males with Severe or Moderately Severe Hemophilia B

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Spain

  • Evaluating Dapagliflozin’s Effect on Immune Activity in Patients with Membranous Nephropathy

    Recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

powered by